Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well giving azacitidine and entinostat work in treating
patients with advanced breast cancer. Drugs used in chemotherapy, such as azacitidine, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Entinostat may stop the growth of tumor cells by blocking some
of the enzymes needed for cell growth. Giving azacitidine together with entinostat may kill
more tumor cells.